A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma-Reference-Cited by-同舟云学术

A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma

Published:2009-01 Issue:7 Volume:50 Page:1110-1118
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Uhm Ji Eun,Kim Kyoung Ha,Yi Seong Yoon,Chang Myung Hee,Park Keon Woo,Kong Doo-Sik,Lee Jung Il,Nam Do Hyun,Park Won,Lim Do Hoon,Kim Seok Jin,Kim Kihyun,Ko Young Hyeh,Kim Won Seog

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190902964776

Reference30 articles.

1. Primary CNS Lymphoma

2. Long-term survival in primary CNS lymphoma.

3. Combined modality therapy for primary CNS lymphoma.

4. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome

5. Treatment for Primary CNS Lymphoma: The Next Step

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis;Neuro-Oncology;2014-05-05

2. Treatment outcomes and survival in patients with primary central nervous system lymphomas treated between 1995 and 2010 – a single centre report;Radiology and Oncology;2012-10-01

3. Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a decision analysis;British Journal of Haematology;2012-06-26

4. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes;Annals of Hematology;2011-04-09

5. Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?;Leukemia & Lymphoma;2011-02